TNAX Biopharma

TNAX Biopharma is a biopharmaceutical company that offers the development and commercialization of novel antibody therapeutics drugs.

Website: tnaxbio.com.

LinkedIn: linkedin.com.

Categories: Health and bio Education.

Sectors: Medtech.

Based in: Japan.

On Recent Funding since: Sep 28, 2026.

Signals

Website registeredFeb 15, 2018 (8 years old)

February 15, 2018
Website created
Date unknown
PPlug and Play · accelerator or program
Source: public.dxp.playbook.vc

AS
Akira Shibuya co-founder and Chief Scientific Officer

source: tnaxbio.com
SA
Shibuya Akira Founder
TM
Tak Mukohira co-founder and Chief Executive Officer

source: tnaxbio.com

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/tnax-biopharma (get a free API key).